John Cavan - Chief Financial Officer, Hepion Pharmaceuticals, Inc

As of May 20, 2021


John Cavan Net Worth

  • Net worth is estimated to be at least $5.76K
  • Owns at least 14,800 units of Hepion Pharmaceuticals, Inc stock

John Cavan Trading

  • Largest purchase of shares was 10,000 units , worth over $20K on February 18, 2021
  • In total has made about 6 transactions over 2 years
  • Usually trades in April, February, July, August, May and November, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Cavan Mailing Address

  • Mailing address is C/o Stemline Therapeutics, Inc. 750 Lexington Avenue, 6th Floor New York NY 10022 NY

Hepion Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units bought on February 18, 2021 by Peter Wijngaard worth over $22K
  • In the last year, insiders at Hepion Pharmaceuticals, Inc bought an estimated value of $197.54K
  • The most active traders are John Cavan, Chief Financial Officer,  Robert Foster, CEO,  and Gary Jacob, Director
  • Insider trading is most common in May and August, with the busiest year in 2020

Hepion Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1